Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung.

Cancer - 1 Feb 1997

Fujisawa T, Yamaguchi Y

Abstract excerpt

BACKGROUND: Cytotoxic activity of peripheral blood lymphocytes obtained during surgery against autologous fresh tumor cells has been reported. However, the role of lymphocyte autologous tumor killing or natural killer activity during the postoperative period remains obscure. In this article, the authors describe the importance of postoperative autologous tumor killing activity as a prognostic factor in patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cytotoxicity, Immunologic
Share to Killer Cells, Natural

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Multivariate Analysis

Share to Phenotype

Share to Prognosis

Share to T-Lymphocytes, Cytotoxic

Source

Identifiers

PMID: 9028357

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung.PMID 9028357Read ↗

Cytolytic potential of peripheral blood T-lymphocytes following adoptive immunotherapy with lymphokine-activated killer cells and low-dose interleukin 2.Semantic proximity Read ↗

Autologous tumor cell killing activity of tumor-associated lymphocytes in patients with head and neck carcinomas.Semantic proximity Read ↗

Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model.Semantic proximity Read ↗

Cytolytic effector cells against human tumors: distinguishing phenotype and function.Semantic proximity Read ↗

Functional characterization of liver-associated lymphocytes in patients with liver metastasis.Semantic proximity Read ↗

Natural killer activity of human liver-derived lymphocytes in various liver diseases.Semantic proximity Read ↗

Functional and phenotypic analysis of lymphocytes in head and neck cancer.Semantic proximity Read ↗

Interleukin-2 activation of cytotoxic cells in postmastectomy seroma.Semantic proximity Read ↗

OK-432 develops CTL and LAK activity in mononuclear cells from regional lymph nodes of lung cancer patients.Semantic proximity Read ↗

A regimen of surgical adjuvant immunotherapy for cancer with interleukin 2 and lymphokine-activated killer cells. Basis, clinical toxicity, and immunomodulatory effects.Semantic proximity Read ↗

Cellular interaction against autologous tumor cells between IL-2-cultured lymphocytes and fresh peripheral blood lymphocytes in patients with breast cancer given immuno-chemotherapy.Semantic proximity Read ↗

Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.